BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BioDelivery Sciences International 

2501 Aerial Center Parkway, Suite 205

Morrisville  North Carolina  27560  U.S.A.
Phone: 919-651-5160 Fax: 919-651-5161


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Delivery





 Company News
BioDelivery Sciences International (BDSI) Appoints Charles J. Bramlage And Dr. Barry I. Feinberg To Its Board Of Directors 7/22/2014 1:27:36 PM
Endo International plc (ENDP), BioDelivery Sciences International (BDSI) Painkiller BEMA® Buprenorphine Effective In Phase 3 Study 7/7/2014 6:10:08 AM
BioDelivery Sciences International (BDSI) Announces Completion Of Patient Enrollment In Its Initial Phase 3 Trial Of Clonidine Topical Gel For Painful Diabetic Neuropathy 6/26/2014 6:23:46 AM
BioDelivery Sciences International (BDSI) Featured On Bloomberg TV, Thestreet.Com And Business News Network 6/12/2014 6:26:23 AM
BioDelivery Sciences International (BDSI) To Present At The William Blair And Wells Fargo Healthcare Conferences 6/10/2014 6:17:45 AM
North Carolina's BioDelivery Sciences International (BDSI) Wins FDA Approval For Opiod Dependence Drug Bunavail 6/6/2014 4:41:22 PM
BioDelivery Sciences International (BDSI) Provides Business Review And Update In Conjunction With Filing Of First Quarter 2014 Financials 5/9/2014 6:58:36 AM
BioDelivery Sciences International (BDSI) To Present At The Bank of America (BAC) Merrill Lynch 2014 Health Care Conference 5/8/2014 7:07:49 AM
BioDelivery Sciences International (BDSI) Announces Randomization Of Over 50% Of Subjects In Its Initial Phase 3 Study Of Clonidine Topical Gel For Painful Diabetic Neuropathy 5/6/2014 9:35:59 AM
BioDelivery Sciences International (BDSI) Announces Four BUNAVAIL Abstracts To Be Presented At The 2014 American Society Of Addiction Medicine Annual Conference 4/7/2014 9:27:01 AM
12345678910...